Most recently, it's been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to a big range of endogenous opioids. Compared with most opioid receptors, this receptor acts to be a scavenger and does not activate a